Prophylactic drugs are commonly used in intensive care units (ICUs) to decrease the risk of development of stress-related upper gastrointestinal tract lesions and bleeding. The aim of this article is to discuss history, incidence, risk factors, past and current research, and current evidence for usefulness of prophylaxis for this disorder. Currently, very good evidence suggests that most ICU patients do not benefit from the widespread application of prophylactic intervention.
No takes yet. Share an insight, caveat, or question.
John Foxworth (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: